Shervin Assassi

57PUBLICATIONS
138CO-AUTHORS
Predictive and prognostic markersNutrigenomics and personalised nutritionGene expression (incl. microarray and other genome-wide approaches)Rheumatology and arthritisNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 30, 2026
Effect of nerandomilast on survival in patients with pulmonary fibrosis.

|Jun 22, 2026
Determinants of Body Mass Index in Early Systemic Sclerosis: Implications for Nutritional Risk Stratification.

|Jun 01, 2026
The Gut-Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort.

|Apr 20, 2026
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.

|Mar 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.

Marlies S Wijsenbeek, Shervin Assassi, Arata Azuma

|Feb 25, 2026
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.

Toby M Maher, R Gisli Jenkins, Francesco Bonella

Pageof 10

Frequent Collaborators

15 joint publications

Dinesh Khanna

14 joint publications

Maureen Mayes

11 joint publications

Tracy M Frech

10 joint publications

Elizabeth R Volkmann